Clinical Trial Update: The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function

View source ↗

Summary

A completed clinical trial investigating the effect of bevacizumab (VEGF antibody) on pituitary function in patients with colorectal cancer, lung cancer, breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Glioblastoma
• Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Colorectal Cancer, Lung Cancer | Status: COMPLETED